Back

Differences in clinical characteristics, angina, and quality of life among patients with microvascular vs vasospastic angina and no obstructive coronary artery disease (ANOCA)

1 September 2024 (11:00 - 11:50)
Organised by: Logo
Congress Presentation Part of: Cardiovascular disease in women (4) Cardiovascular Disease in Women ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Odayme Quesada

The Christ Hospital Health Network, Cincinnati (United States of America)

6 More presentations in this session

Presentation thumbnail
Gender-differences in Polyvascular disease: implications for lipid-lowering management and cardiovascular outcomes
Doctor A. Katasako-Yabumoto (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Angina pectoris after coronary angiography or revascularization in pre- and postmenopausal women with coronary artery disease
Doctor M. Eskuri (Oulu, FI)
Abstract Slides Video
Presentation thumbnail
Gender differences in long-term survival after coronary artery bypass surgery is womens cardiovascular health at risk?
Miss I. Sousa (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Sex differences in severe aortic stenosis undergoing surgical replacement
Doctor G. Panichella (Florence, IT)
Abstract Slides Video
Presentation thumbnail
Long-term survival after coronary artery bypass grafting comparing bilateral versus single internal mammary artery in a women cohort
Miss I. Sousa (Porto, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular disease in women (4)

The Event

Event poster

ESC Congress 2024

1 September 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Evaluation of coronary microvascular dysfunction and vasospasm in patients with angina and non-obstructive coronary artery disease
thumbnail
Congress Presentation
Coronary vasomotor disorders in ANOCA patients: insights from the CADOSA registry.
thumbnail
Congress Session
Diagnosis and treatment of microvascular and epicardial coronary artery disease

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources